Vice President, Program Management
Codiak is the leader in the emerging field of exosome therapeutics, working to harness the power of this cellular messenger system to create potentially life-changing medicines. A venture-backed startup founded in 2015, Codiak has rapidly built a proprietary technology platform for exosome engineering and manufacturing that allows for precise targeting of important molecular pathways, opening the door to the development of therapies for cancer and other diseases. Led by an experienced and dedicated team, Codiak has at its foundation a positive and collaborative culture that is deeply rooted in cutting edge science and promotes opportunity for growth.
Responsible for creating and leading the Program Management function at Codiak. Works with Codiak leadership team to establish governance for portfolio of assets. Provides program leadership and management for portfolio of Research assets along with one or more assets in pre-clinical and beyond as required. Facilitates long-range planning, prioritization discussions and other corporate activities as required.
- 1. Establishes program management function including appropriate program management tools, processes and systems ensuring efficiency and effectiveness
- 2. Partners with Research and Clinical leads to develop product strategy in line with broader company strategy. Facilitates the creation of sub-team activities such as clinical development plan, regulatory strategy, etc., through cross functional discussions and driving decision-making to achieve product goals within stated time frames and resources.
- 3. Works with the functional team representatives to identify potential issues and ensures contingency planning, problem-solving, and communications as appropriate.
- 4. Hires and mentors additional Program Managers as appropriate and as pipeline requires. Supports Program managers in building team effectiveness, planning, and navigating issues
- part of the planning process; works closely with the finance organization to ensure appropriate long-range planning and budgetary assumptions
- 6. Drive program/asset communication strategy and ensure that communications are managed consistently in a timely manner, and with appropriate context;
- • Minimum B.S. in biological sciences or related scientific field. Advanced degree preferred.
- • 15+ years of relevant industry experience;
- • Demonstrated track record of project managing multi-disciplinary teams from lead identification to clinical proof of concept and pivotal studies;
- • Significant experience partnering with Clinical Operations, Regulatory, CMC and/or other functional areas preferred.
- • Strong drug development acumen and integrity with the ability to drive tough decisions,
- • Strategic thinker with high energy level and the ability to thrive in a dynamic, ambiguous, fast-paced, respectful environment;
- • Able to confidently manage conflicting priorities; collaborate with functional representatives to timely identify and address resource limitation; regularly update Leadership Team;
- • Mature understanding of team and organizational dynamics and active listening skills with the ability to provide and take constructive feedback;
- • Exceptional project/program management skills, specifically timeline and budget development and oversight;
- • Biologics drug development experience and immuno-oncology experience is a plus;
- • Significant cross-functional leadership capabilities; ability to lead, collaborate and influence without authority;
- • Compassionately assertive; able to tactfully address concerns or conflicts openly within core and extended teams;
- • Critical and objective interpretation of business, scientific and commercial information is critical for success in this position. Solid analytical skills for integrating and interpreting interdisciplinary project information.
- • Energetic, highly organized, detail-oriented, diplomatic and calm under pressure;
- • Displays strong presentation skills; effective at summarizing and presenting decision points and key considerations;
- • Excellent oral, written and presentation communication skills;
- • Comfortable with change and the ability to navigate both success and failure gracefully, with unquestionable ethics and integrity;
Compensation & Benefits
Codiak provides competitive compensation and benefits package that support and reward the contributions of each member of the team.
Apply TodayThose interested in joining the team effort at Codiak BioSciences to advance the nascent and exciting field of exosome technology into therapeutics with transformative potential are invited to email their CV.
Recent discoveries have demonstrated that exosomes derived from normal cells can act as a potent and safe delivery system for multiple therapeutic payloads. These small vesicles, which leave cells and travel throughout the body, can mediate dramatic effects in animal models of disease.
We are developing a broad platform for the delivery of macromolecules to the cytoplasm of diverse cells and tissues, to create a proprietary pipeline of novel, targeted medicines for diseases with high unmet medical need. The company’s technology exploits the natural propensity of exosomes to transmit macromolecule payloads between cells to create a pipeline of drugs across a broad range of diseases, including those associated with currently “undruggable” targets. While our initial focus is on oncology/immuno-oncology, this approach also offers significant potential in hematology, neurology and gene therapy and other therapy areas.
We are now producing drug candidate exosomes using the engExTM platform, our novel therapeutic engine for exosomes. We tailor exosomes to express molecules on their surfaces and/or deliver specific cargo inside. This affords us the flexibility for designing proprietary drug candidates; exosomes can be mixed and matched into rational and targeted combinations with the potential for a broad therapeutic platform.
As of December 2017, Codiak has raised a combined $168.5M in Series A-C financing. The company maintains partnerships with academic exosome labs and has multiple paths to clinical and commercial success through the breadth of the company’s research, strength of its IP position and proprietary innovation behind its production capabilities.
Codiak’s CEO and first employee Doug Williams, Ph.D., (former EVP of Biogen R&D, CEO of ZymoGenetics) espouses the belief that inspired employees create great science. Employees treat the company as if it was their own and report that there is “direct and respectful communication,” and “trust that teammates will do the right thing and never compromise integrity.”
Named one of 11 disruptive startups “on a do-or-die mission to launch new meds” by Endpoints News in January 2018, Codiak is in the heart of Boston’s biotechnology hub at 500 Technology Square in Cambridge, Massachusetts.
Codiak BioSciences is an Equal Opportunity Employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status.